Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$280,300
-3.47%
Shares
Shares Volume: 10,000 Shares
Average Share Price: $28.03
INSIDER
Young Jonathan
Chief Operating Officer (Officer)
reported on Jan 6 2025
traded on Jan 2 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 278,083 |
| PURCHASES/SALES 1Y | 0 / 14 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $327,085.13 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 46 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $586,902.37 |
| COMPANY PREVIOUS TRADES |